Skip to main content

Site notifications

VesiCulture BCG 30mg/vial powder for bladder irrigation (AJ Vaccines)

Section 19A approved medicine
VesiCulture BCG 30mg/vial powder for bladder irrigation (AJ Vaccines)
Section 19A approval holder
Link Medical Products Pty Ltd ABN 73 010 971 516
Phone
1800 181 060
Approved until
Status
Current
Medicines in short supply/unavailable
ONCOTICE BCG 5 hundred million CFU powder for injection vial - ARTG 59912
Indication(s)

Treatment of primary or recurrent carcinoma in situ (CIS) of the urinary bladder.

Intravesicular BCG is also used after transurethral resection for the prevention of recurrence of high grade and/or relapsing superficial papillary transitional cell carcinoma of the urinary bladder (viz papillary carcinoma stage TA [grade 2 or 3] or T1 [grade 1, 2, or 3]).

Intravesicular BCG is only recommended for stage TA grade 1 tumours, when there is judged to be a high risk of tumour recurrence.

Images
Picture of BCG Culture SSI 30mg/vial (AJ Vaccines) carton label
Picture of BCG Culture SSI 30mg/vial (AJ Vaccines) vial label
Published

Help us improve the Therapeutic Goods Administration site